290
Participants
Start Date
September 23, 2019
Primary Completion Date
May 1, 2026
Study Completion Date
May 1, 2029
Tamoxifen Citrate
current standard of care is 5 years endocrine therapy after early breast cancer. Intervention will test if 2 years is adequate for population with low recurrence risk based on genomic tissue based test
BC Cancer, Vancouver
Collaborators (1)
Canadian Cancer Society (CCS)
OTHER
NanoString Technologies, Inc.
INDUSTRY
British Columbia Cancer Agency
OTHER